, Giuseppe Vergaro 2, 3 and Michele Emdin 2, 3 High levels of total and low-density lipoprotein cholesterol (LDL-C) and low levels of high-density lipoprotein cholesterol (HDL-C) are established cardiovascular risk factors. 1 Additionally, multiple epidemiological studies, including genetically-based analyses, have demonstrated that cardiovascular risk is related to triglycerides independently of cholesterol levels. 2 Hyperlipidaemia was traditionally seen as a problem of healthy, industrialized nations, where its prevalence is indeed significant: for example, over 12% of adults aged 20 years or older in the United States have total cholesterol >240 mg/dL, and more than 18% have HDL-C <40 mg/dL (www.cdc.gov/ nchs/data/hus/hus15.pdf). In countries experiencing a rapid economic development in recent years, the prevalence of hyperlipidaemia has increased dramatically because of social and economic development and associated lifestyle changes. In a population survey carried out in China, the age-standardized prevalence of hyperlipidaemia was 36% (34% among men and 38% among women). 3 Among patients with hyperlipidaemia, 44% had isolated hypertriglyceridaemia, 15% had isolated hypercholesterolaemia, 13% had mixed hyperlipidaemia, and 28% had isolated low HDL-C. The peak prevalence of hyperlipidaemia in men was between 30 and 39 years (48%), then declined gradually; in women, the prevalence of hyperlipidaemia increased with age, with the peak occurring after age 60 (46%). 3 In parallel, cardiovascular disorders have become the most common cause of death in China, with cardiovascular death in urban and rural areas increasing to 42% and 45%, respectively, in 2013, significantly higher than that for cancer (26% and 22%). 4 Insomnia symptoms have been associated with an increased risk of cardiovascular events, 5 and an association between reduced sleep duration and/or quality and abnormal lipid profile, particularly hypercholesterolaemia, has been repeatedly reported. Experimental sleep restriction has been shown to significantly increase total cholesterol and LDL-C levels in postmenopausal women treated with hormone replacement therapy. 6 Cross-sectional associations have been found between short sleep durations and lower HDL-C levels in adult American women with type 2 diabetes 7 and in adult Japanese women from the general population. 8 Short sleep duration was found to be associated with the highest total cholesterol levels among all sleep duration categories in cross-sectional analyses that included both men and women from Norwegian 9 and Korean adult populations.
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A number of mechanisms could mediate the relationship between inadequate sleep and hypercholesterolaemia. First, short sleep has previously been associated with abnormalities in hormones regulating metabolism (leptin and ghrelin), 11, 12 as well as energy balance 13, 14 and duration and timing of meals. 15 Increased appetite could raise body weight and increase dietary intake of cholesterol, trans-fats and saturated fats. 16 Second, inadequate sleep is associated with daytime fatigue, possibly limiting physical activity, which has been shown to lower LDL-C and raise HDL-C levels. 17 Third, inadequate sleep (possibly because of obstructive apnoeas) is associated with sympathetic activation, 18 which may increase blood lipids through catecholamine-induced lipolysis and the release of free fatty acids that serve as substrate for triglyceride synthesis and hepatic very low-density lipoprotein cholesterol production. 19 Epidemiological studies have repeatedly reported that the risk of coronary events 20 and mortality 21 increases with long sleep duration as well. Accordingly, there are a few reports of an association between longer sleep duration and abnormal lipid profile. Most notably, longer sleep duration was positively associated with total cholesterol levels, and a higher total/HDL-C ratio in elderly subjects (57-97 years) from the Rotterdam Study cohort, 22 and in women aged >20 years from Japan. 8 The population study by Wang et al., published in the present issue of the European Journal of Preventive Cardiology, adds to our knowledge on this field. The authors evaluated the relationship between sleep duration and quality and hyperlipidaemia in 20,712 retired workers enrolled in the Dongfeng-Tongji cohort study, based in a central region of China. 23 Sleep duration was self-reported and sleep quality during the previous year was evaluated through a modified version of the Pittsburgh Sleep Quality Index; hyperlipidaemia was defined as total cholesterol 5.2 mmol/L (201 mg/dL) or triglycerides 1.70 mmol/L (151 mg/dL), and/or self-reported physician-diagnosed hyperlipidaemia or taking specific treatment for previously diagnosed hyperlipidaemia. Compared with subjects with average sleep duration (7-8 h), those with a sleep duration of 10 h had a higher prevalence of hyperlipidaemia, as well as those with impaired or poor sleep quality compared with those with good sleep quality, after adjusting for potential confounders (sociodemographic characteristics, body mass index, comorbidities, medications, lifestyle, beverage consumption, shift work, among others). Among subjects without hyperlipidaemia at baseline (n ¼ 6129), the risk of developing hyperlipidaemia during a mean follow-up of 4.6 years increased with the number of sleep hours at baseline (9-10 h: hazard ratio 1.19, 95% confidence interval (CI) 1.04-1.35; 10 hours: hazard ratio 1.27, 95% CI 1.02-1.58), while the incidence of hyperlipidaemia was apparently unaffected by sleep quality. 23 As is the case for all population studies, this study does not sufficiently explain the relationship between longer sleep duration and hyperlipidaemia. Nevertheless, some mechanisms can be proposed. First, the results point to an association between longer sleep duration and worse sleep quality. Indeed, longer time in bed has been linked to increased sleep fragmentation, wake after sleep onset and sleep latency. 24 This association might emerge more clearly in subjects with unrestricted sleep duration, such as retired workers, than in younger individuals. Second, despite extensive adjustment for potential confounders, it seems plausible that subjects sleeping longer hours are also those with poorer health status, lower levels of physical activity, and possibly also an overall less healthy lifestyle. Further, mood disorders possibly associated with abnormal sleep quality and duration, namely depression, have also been linked to metabolic syndrome, and most notably to hyperlipidaemia. 25 Third, it is intriguing to consider that cholesterol synthesis is more active during sleep, 26 which explains the recommendation to administer statins before going to bed. Further mechanisms (changes in cytokine expression, decreased resistance to stress and disease, shortened daytime period of the circadian cycle, lack of stressors increasing longevity) have been proposed to explain the association between longer sleep duration and mortality; 26 under this perspective, altered lipid metabolism might be an element of a more general derangement of body homeostasis.
While we wait for studies establishing the mechanisms of the proposed relationship, we can recommend greater attention to patient sleep quality, with the goals of improving patient well-being, and possibly their lipid profile and cardiovascular outcome. Patients should be asked for symptoms possibly related to sleep disturbances; when suspected, sleep disorders should be investigated through polysomnography or other systems for cardiorespiratory monitoring. Beyond therapies for the obstructive sleep apnoea syndrome, lifestyle interventions (such as healthy eating and physical activity) and the treatment of mood disorders might prove valuable.
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